L. Recherche and . Cancer, Association Neurofibromatose et Recklinghausen (ANR) and Institut National du Cancer

D. Lallemand, M. Curto, I. Saotome, M. Giovannini, and A. I. Mcclatchey, NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions, Genes Dev, vol.17, pp.1090-1100, 2003.

A. I. Mcclatchey, I. Saotome, V. Ramesh, J. F. Gusella, and T. Jacks, The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation, Genes & Dev, vol.11, pp.1253-1265, 1997.

M. Giovannini, E. Robanus-maandag, M. Van-der-valk, M. Niwa-kawakita, V. Abramowski et al., Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2, Genes & Dev, vol.14, pp.1617-1630, 2000.

J. L. Kissil, E. W. Wilker, K. C. Johnson, M. S. Eckman, M. B. Yaffe et al., Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1, Mol Cell, vol.12, pp.841-849, 2003.

A. Tikoo, M. Varga, V. Ramesh, J. Gusella, and H. Maruta, An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin), J. Biol. Chem, vol.269, pp.23387-23390, 1994.

H. Morrison, T. Sperka, J. Manent, M. Giovannini, H. Ponta et al., Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac, Cancer Res, vol.67, pp.520-527, 2007.

M. F. James, S. Han, C. Polizzano, S. R. Plotkin, B. D. Manning et al., NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth, Mol. Cell. Biol, vol.29, pp.4250-4261, 2009.

S. Maitra, R. M. Kulikauskas, H. Gavilan, and R. G. Fehon, The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling, Curr. Biol, vol.16, pp.702-709, 2006.

D. Lallemand, J. Manent, A. Couvelard, A. Watilliaux, M. Siena et al., Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas, Oncogene, vol.28, pp.854-865, 2009.

W. Li, L. You, J. Cooper, G. Schiavon, A. Pepe-caprio et al., , 2010.

, Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus, Cell, vol.140, pp.477-490

N. Zhang, H. Bai, K. K. David, J. Dong, Y. Zheng et al., The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals, Dev. Cell, vol.19, pp.27-38, 2010.

T. Su, M. Z. Ludwig, J. Xu, and R. G. Fehon, Kibra and Merlin Activate the Hippo Pathway Spatially Distinct from and Independent of Expanded, Dev Cell, vol.40, pp.478-490, 2017.

W. Li, J. Cooper, L. Zhou, C. Yang, H. Erdjument-bromage et al., Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus, Cancer cell, vol.26, issue.1, pp.48-60, 2014.

A. Boin, A. Couvelard, C. Couderc, I. Brito, D. Filipescu et al., Proteomic screening identifies a YAPdriven signaling network linked to tumor cell proliferation in human schwannomas, Neuro Oncol, vol.16, issue.9, pp.1196-209, 2014.

W. Guerrant, S. Kota, S. Troutman, V. Mandati, M. Fallahi et al., YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis, Cancer Research, vol.76, pp.3507-3519, 2016.

T. Muranen, M. Grönholm, G. H. Renkema, and O. Carpén, Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin, Oncogene, vol.24, pp.1150-1158, 2005.

M. Grönholm, T. Muranen, G. G. Toby, T. Utermark, C. O. Hanemann et al., A functional association between merlin and HEI10, a cell cycle regulator, Oncogene, vol.25, pp.4389-4398, 2006.

A. M. Hebert, B. Duboff, J. B. Casaletto, A. B. Gladden, and A. I. Mcclatchey, , 2012.

M. , ERM proteins establish cortical asymmetry and centrosome position, Genes Dev, vol.26, pp.2709-2723

S. Carreno, I. Kouranti, E. S. Glusman, M. T. Fuller, A. Echard et al., Moesin and its activating kinase Slik are required for cortical stability and microtubule organization in mitotic cells, J. Cell Biol, vol.180, pp.739-746, 2008.

P. Kunda, A. E. Pelling, T. Liu, and B. Baum, Moesin controls cortical rigidity, cell rounding, and spindle morphogenesis during mitosis, Curr. Biol, vol.18, pp.91-101, 2008.

S. Solinet, K. Mahmud, S. F. Stewman, K. Ben-el-kadhi, B. Decelle et al., The actin-binding ERM protein Moesin binds to and stabilizes microtubules at the cell cortex, J. Cell Biol, vol.202, issue.2, pp.251-260, 2013.

M. Machicoane, C. A. De-frutos, J. Fink, M. Rocancourt, Y. Lombardi et al., SLK-dependent activation of ERMs controls LGN-NuMA localization and spindle orientation, J. Cell Biol, vol.205, issue.6, pp.791-799, 2014.

T. Muranen, M. Gronholm, A. Lampin, D. Lallemand, F. Zhao et al., The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton, Human Molecular Genetics, vol.16, issue.14, pp.1742-1751, 2007.

Z. Smole, C. R. Thoma, K. T. Applegate, M. Duda, K. L. Gutbrodt et al., Tumor Suppressor NF2/Merlin Is a Microtubule Stabilizer, Cancer Res, vol.74, pp.353-362, 2014.

, kinase activities in mitotic cells, Sci Signal, vol.4, issue.179

M. Giovannini, E. Robanus-maandag, M. Niwa-kawakita, M. Van-der-valk, J. M. Woodruff et al., Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein, Genes & Dev, vol.13, pp.978-986, 1999.

N. Yabuta, S. Mukai, N. Okada, Y. Aylon, and H. Nojima, The tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis, Cell Cycle, vol.10, issue.16, pp.2724-2760, 2011.

M. Laulajainen, T. Muranen, T. A. Nyman, O. Carpén, and M. Grönholm, Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin, Neoplasia, vol.13, pp.643-652, 2011.

D. Reboutier, C. Benaud, and C. Prigent, Aurora A's Functions During Mitotic Exit: The Guess Who Game, Front Oncol, vol.5, p.290, 2015.

O. Gavet and J. Pines, Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis, Dev Cell, vol.18, pp.533-543, 2010.

I. Sher, C. O. Hanemann, P. A. Karplus, and A. Bretscher, The tumor suppressor merlin controls growth in its open state, and phosphorylation converts it to a less-active more-closed state, Dev. Cell, vol.22, issue.4, pp.703-708, 2012.

B. T. Fievet, A. Gautreau, C. Roy, D. Maestro, L. Mangeat et al., , 2004.

, Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin, J Cell Biol, vol.164, issue.5, pp.653-659

W. Li, J. Cooper, M. A. Karajannis, and F. G. Giancotti, Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus, EMBO reports, vol.13, issue.3, pp.204-215, 2012.

M. A. Lopez-lago, T. Okada, M. M. Murillo, N. Socci, and F. G. Giancotti, Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling, Mol Cell Biol, vol.29, pp.4235-4249, 2009.

R. G. Fehon, A. I. Mcclatchey, and A. Bretscher, Organizing the cell cortex: the role of ERM proteins, Nat Rev Mol Cell Biol, vol.11, pp.276-287, 2010.

D. Pan, The Hippo signaling pathway in development and cancer, Dev Cell, vol.19, pp.491-505, 2010.

B. J. Pellock, E. Buff, K. White, and I. K. Hariharan, The Drosophila tumor suppressors Expanded and Merlin differentially regulate cell cycle exit, apoptosis, and Wingless signaling, Dev. Biol, vol.304, pp.102-115, 2007.

S. Moleirinho, S. Hoxha, V. Mandati, G. Curtale, S. Troutman et al., Regulation of localization and function of the transcriptional co-activator YAP by angiomotin, vol.6, p.23966, 2016.

Y. T. Kschonsak and . Hoffmann, Activated ezrin controls MISP levels to ensure correct NuMA polarization and spindle orientation, J Cell Sci, vol.131, issue.10, 2018.

J. J. Meng, D. J. Lowrie, H. Sun, E. Dorsey, P. D. Pelton et al., Interaction between two isoforms of the NF2 tumor suppressor protein, Merlin, and between Merlin and ezrin, suggests modulation of ERM proteins by Merlin, Neurosci Res, vol.62, issue.4, pp.491-502, 2000.

N. J. Ganem and D. Pellman, Linking abnormal mitosis to the acquisition of DNA damage, J Cell Biol, vol.199, issue.6, pp.871-81, 2012.

L. Kluwe and V. F. Mautner, A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2, Human Genet, vol.97, issue.2, pp.224-231, 1996.

M. H. Ruttledge, A. A. Andermann, C. M. Phelan, J. O. Claudio, F. Y. Han et al., Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease, Am J Hum Genet, vol.59, issue.2, pp.331-373, 1996.

M. E. Baser, J. M. Friedman, D. Aeschliman, H. Joe, A. J. Wallace et al., Predictors of the risk of mortality in neurofibromatosis 2, Am J Hum Genet, vol.71, issue.4, pp.715-738, 2002.

D. R. Scoles, M. E. Baser, and S. M. Pulst, A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes, Neurology, vol.47, issue.2, pp.544-550, 1996.

L. Sherman, H. M. Xu, R. T. Geist, S. Saporito-irwin, N. Howells et al., Interdomain binding mediates tumor growth suppression by the NF2 gene product, Oncogene, vol.15, pp.2505-2509, 1997.

D. Lallemand, A. L. Saint-amaux, and M. Giovannini, Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells, J Cell Sci, vol.122, pp.4141-4149, 2009.

M. Laulajainen, M. Melikova, T. Muranen, O. Carpén, and M. Grönholm, Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity, J Cell Mol Med, vol.16, pp.2161-2175, 2012.

A. Bretscher, K. Edwards, and R. G. Fehon, ERM proteins and merlin: integrators at the cell cortex, Nat Rev Mol Cell Biol, vol.3, pp.586-599, 2002.

A. Schulz, S. L. Baader, M. Niwa-kawakita, M. J. Jung, R. Bauer et al., Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy, Nat Neurosci, vol.16, pp.426-433, 2013.

K. Chinthalapudi, V. Mandati, J. Zheng, A. J. Sharff, G. Bricogne et al., Lipid binding promotes the open conformation and tumor-suppressive activity of neurofibromin 2, Nat Commun, vol.9, issue.1, p.1338, 2018.

W. Xing, M. Li, F. Zhang, X. Ma, J. Long et al., The conformation change and tumor suppressor role of Merlin are both independent of Serine 518 phosphorylation, Biochem Biophys Res Commun, vol.493, issue.1, pp.46-51, 2017.